Skip to main content
SpringerLink
Log in

Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

Up to date, schistosomiasis is still prevalent worldwide. It is estimated that more than 200 million individuals are infected, and 120 million suffer from clinical morbidity. Facing such huge cases of schistosomiasis, only heavy reliance on a single praziquantel for schistosomiasis control does not adapt and may promote the selection and spread of drug-resistant parasites. Therefore, it is an urgent need to develop the new antischistosomal drug. In 2008–2009, the antimalarial drug mefloquine, an arylaminoalcohol compound, has been found to be effective against schistosomes. According to the experimental studies, the deepest impression on the antischistosomal properties of mefloquine can be summarized as following points: (1) single dose of mefloquine possesses potential effect against three major species of schistosomes (Schistosoma mansoni, Schistosoma haematobium, and Schistosoma japonicum) infecting humans; (2) the drug displays similar effects against developing stages of juvenile and adult schistosomes, which are superior to that of artemisinins and praziquantel; (3) in vitro mefloquine exerts direct killing effect on juvenile and adult schistosomes, while in vivo, the efficacy of the drug is independent to host immune response, (4) mefloquine causes extensive and severe morphological, histopathological, and ultrastructural damage to adult and juvenile schistosomes, particularly, the worm tegument, musculature, gut, and vitelline glands of female worms are the key sites attacked by the drug; (5) combined treatment with mefloquine and praziquantel, or artemisinins shows synergistic effect against schistosome in experimental therapy,while in initially clinical trial, mefloquine in combination with artesunate also exhibits higher cure rates against schistosomiasis hematobia and schistosomiasis mansoni, and (6) several mefloquine-related arylmethanols exhibit potential effect against schistosomes in vivo, which is a useful clue helpful for development of new antischistosomal compound. In the present review, we have summarized the major results published in recent years, and the significance as well as the prospect for the future study of mefloquine have been discussed briefly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figs. 1–4
Fig. 5–8
Fig. 9–12
Figs. 13–18
Figs. 19–22
Figs. 23–26
Figs. 27–30
Fig. 31

Similar content being viewed by others

References

  • Abdulla MH, Lim KC, Sajid M, McKerrow JH, Caffrey CR (2007) Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med 4:e14

    Article  PubMed  Google Scholar 

  • Basra A, Basra A, Mombo-Ngoma G, Capan Melser M, Akerey Diop D, Würbel H, Mackanga JR, Fürstenau M, Manego Zoleko R, Adegnika AA, Gonzalez R, Menendez C, Kremsner PG, Ramharter M (2013) Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial. Clin Infect Dis 56:e68–e75

    Article  PubMed  CAS  Google Scholar 

  • Black CL, Steinauer ML, Mwinzi PN, Evan Secor W, Karanja DM, Colley DG (2009) Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya. Trop Med Int Health 14:450–457

    Article  PubMed  CAS  Google Scholar 

  • Botros S, William S, Hammam O, Zídek Z, Holý A (2003) Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy) propyl]adenine against schistosomiasis mansoni in mice[J]. Antimicrob Agents Chemother 47:2858–3853

    Article  Google Scholar 

  • Brindley PJ, Sher A (1987) The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J Immunol 139:215–220

    PubMed  CAS  Google Scholar 

  • Caffrey CR (2007) Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol 11:433–439

    Article  PubMed  CAS  Google Scholar 

  • Chen MG (2005) Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years’ experience. Acta Trop 96:168–176

    Article  PubMed  CAS  Google Scholar 

  • Danso-Appiah A, de Vlas SJ (2002) Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol 18:125–129

    Article  PubMed  Google Scholar 

  • Davis TM, Karunajeewa HA, Ilett KF (2005) Artemisinin-based combination therapies for uncomplicated malaria. Med J 182:181–185

    Google Scholar 

  • Doenhoff MJ (1989) The immune-dependence of chemotherapy in experimental schistosomiasis. Mem Inst Oswaldo Cruz 84(Suppl 1):31–37

    Article  PubMed  Google Scholar 

  • Doenhoff MJ, Cioli D, Utzinger J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21:659–667

    Article  PubMed  CAS  Google Scholar 

  • Eissa MM, El-Azzouni MZ, Amer EI, Baddour NM (2011) Miltefosine, a promising novel agent for schistosomiasis mansoni. Int J Parasitol 41:235–242

    Article  PubMed  CAS  Google Scholar 

  • el-Lakkany NM, el-Din SH, Sabra AN, Hammam OA (2011) Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni. Mem Inst Oswaldo Cruz 106:814–822

    PubMed  CAS  Google Scholar 

  • Fenwick A, Savioli L, Engels D, Bergquist NR, Todd MH (2003) Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 19:509–515

    Article  PubMed  CAS  Google Scholar 

  • Holtfreter MC, Loebermann M, Klammt S, Sombetzki M, Bodammer P, Riebold D, Kinzelbach R, Reisinger EC (2011) Schistosoma mansoni: schistosomicidal effect of mefloquine and primaquine in vitro. Exp Parasitol 127:270–276

    Article  PubMed  CAS  Google Scholar 

  • Ingram K, Ellis W, Keiser J (2012) Antischistosomal activities of mefloquine-related arylmethanols. Antimicrob Agents Chemother 56:3207–3215

    Article  PubMed  CAS  Google Scholar 

  • Ingram K, Duthaler U, Vargas M, Ellis W, Keiser J (2013) Disposition of mefloquine and enpiroline is highly influenced by a chronic Schistosoma mansoni infection. Antimicrob Agents Chemother. PMID: 23836173

  • Keiser J, Utzinger J (2007) Artemisinins and synthetic trioxolanes for treatment of helminth infections. Curr Opin Infect Dis 20:605–612

    Article  PubMed  CAS  Google Scholar 

  • Keiser J, Chollet J, Xiao SH, Mei JY, Jiao PY, Utzinger J, Tanner M (2009a) Mefloquine—an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl Trop Dis 3:e350

    Article  PubMed  Google Scholar 

  • Keiser J, Odermatt P, Tesana S (2009b) Dose–response relationships and tegumental surface alterations in Opisthorchis viverrini following treatment with mefloquine in vivo and in vitro. Parasitol Res 105:261–266

    Article  PubMed  Google Scholar 

  • Keiser J, N’Guessan NA, Adoubryn KD, Silué KD, Vounatsou P, Hatz C, Utzinger J, N’Goran EK (2010a) Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis 50:1205–1213

    Article  PubMed  CAS  Google Scholar 

  • Keiser J, Vargas M, Doenhoff MJ (2010b) Activity of artemether and mefloquine against juvenile and adult Schistosoma mansoni in athymic and immuno-competent NMRI mice. Am J Trop Med Hyg 82:112–114

    Article  PubMed  CAS  Google Scholar 

  • Keiser J, Manneck T, Vargas M (2011) Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro. J Antimicrob Chemother 66:1791–1797

    Article  PubMed  CAS  Google Scholar 

  • Keiser J, Utzinger J (2012) Antimalarials in the treatment of schistosomiasis. Curr Phamaceut Design 18:3531–3538

    CAS  Google Scholar 

  • Kuntz AN, Davioud-Charvet E, Sayed AA, Califf LL, Dessolin J, Arnér ES, Williams DL (2007) Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med 4:e206

    Article  PubMed  Google Scholar 

  • Küster T, Stadelmann B, Hermann C, Scholl S, Keiser J, Hemphill A (2011) In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis. Antimicrob Agents Chemother 55:713–721

    Article  PubMed  Google Scholar 

  • Le WJ, You JQ, Yang YQ, Mei JY, Guo HF, Yang HZ, Zhang CW (1982) Studies on the efficacy of artemether in experimental schistosomiasis. Acta Pharmaceutica Sin 17:187–193

    CAS  Google Scholar 

  • Li SW, Wu LJ, Liu ZD, Hu LS, Xu YX, Liu YM, Liu X, Fang JT (1996) Studies on prophylactic effect of artesunate on schistosomiasis japonica. Chin Med J 109:848–853

    PubMed  CAS  Google Scholar 

  • Manneck T, Haggenmuller Y, Keiser J (2010) Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology 137:85–98

    Article  PubMed  CAS  Google Scholar 

  • Manneck T, Braissant O, Ellis W, Keiser J (2011) Schistosoma mansoni: antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo. Exp Parasitol 127:260–269

    Article  PubMed  CAS  Google Scholar 

  • Manneck T, Keiser J, Muller J (2012) Mefloquine interferes with glycolysis in schistosomula of Schistosoma mansoni via inhibition of enolase. Parasitology 139:497–505

    Article  PubMed  CAS  Google Scholar 

  • Moreira LS, Piló-Veloso D, de Mello RT, Coelho PM, Nelson DL (2007) A study of the activity of 2-(alkylamino)-1-phenyl-1-ethanethiosulfuric acids against infection by Schistosoma mansoni in a murine model. Trans R Soc Trop Med Hyg 101:385–390

    Article  PubMed  CAS  Google Scholar 

  • Ohnmacht CJ, Patel AR, Lutz RE (1971) Antimalarials. 7. Bis(trifluoromethyl)-(2-piperidyl)-4-quinolinemethanols. J Med Chem 14:926–928

    Article  PubMed  CAS  Google Scholar 

  • Raso G, N’Goran EK, Toty A, Luginbühl A, Adjoua CA, Tian-Bi NT, Bogoch II, Vounatsou P, Tanner M, Utzinger J (2004) Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d’Ivoire. Trans R Soc Trop Med Hyg 98:18–27

    Article  PubMed  CAS  Google Scholar 

  • Sabah AA, Fletcher C, Webbe G, Doenhoff MJ (1986) Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 61:294–303

    Article  PubMed  CAS  Google Scholar 

  • Sayed AA, Simeonov A, Thomas CJ, Inglese J, Austin CP, Williams DL (2008) Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat Med 14:407–412

    Article  PubMed  CAS  Google Scholar 

  • Soukhathammavong P, Odermatt P, Sayasone S, Vonghachack Y, Vounatsou P, Hatz C, Akkhavong K, Keiser J (2011) Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. Lancet Infect Dis 11:110–118

    Article  PubMed  CAS  Google Scholar 

  • Stadelmann B, Küster T, Scholl S, Barna F, Kropf C, Keiser J, Boykin DW, Stephens CE, Hemphill A (2011) In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother 55:4866–4872

    Article  PubMed  CAS  Google Scholar 

  • Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6:411–425

    Article  PubMed  Google Scholar 

  • Strauch S, Jantratid E, Dressman JB, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM (2011) Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochloride. J Pharm Sci 100:11–21

    Article  PubMed  CAS  Google Scholar 

  • Sweeney TR (1981) The present status of malaria chemotherapy: mefloquine, a novel antimalarial. Med Res Rev 1:281–301

    Article  PubMed  CAS  Google Scholar 

  • Utzinger J, Chollet J, You JQ, Jy M, Tanner M, Xiao SH (2001) Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Trop 80:9–18

    Article  PubMed  CAS  Google Scholar 

  • Utzinger J, Keiser J (2004) Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother 5:263–285

    Article  PubMed  CAS  Google Scholar 

  • Utzinger J, Xiao SH, Tanner M, Keiser J (2007) Artemisinins for schistosomiasis and beyond. Curr Opin Investig Drugs 8:105–116

    PubMed  CAS  Google Scholar 

  • Van Nassauw L, Toovey S, Van Op den bosch J, Timmermans JP, Vercruysse J (2008) Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice. Travel Med Infect Dis 6:253–258

    Article  PubMed  Google Scholar 

  • Vennerstrom JL, Arbe-Barnes S, Brun R, Charman SA, Chiu FCK, Chollet J, Dong YX, Dorn A, Hunziker D, Matile H, McIntosh K, Padmanilayam M, Santo Tomas J, Scheurer C, Scorneaux B, Tang YQ, Urwyler H, Wittlin S, Charman WN (2004) Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430:900–904

    Article  PubMed  CAS  Google Scholar 

  • Xiao SH (2005) Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop 96:153–167

    Article  PubMed  CAS  Google Scholar 

  • Xiao SH, Yue WJ, Yang YQ, You JQ (1987) Susceptibility of Schistosoma japonicum of different developmental stages to praziquantel. Chin Med J 100:759–768

    PubMed  CAS  Google Scholar 

  • Xiao SH, You JQ, Yang YQ, Wang CZ (1995) Experimental studies on early treatment of schistosomal infection with artemether. Southeast Asian J Trop Med Public Health 26:306–318

    PubMed  CAS  Google Scholar 

  • Xiao SH, Booth M, Tanner M (2000a) The prophylactic effects of artemether against Schistosoma japonicum infections. Parasitol Today 16:122–126

    Article  PubMed  CAS  Google Scholar 

  • Xiao SH, You JQ, Mei JY, Guo HF, Jiao PY, Tanner M (2000b) Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits. Parasitol Int 49:25–30

    Article  Google Scholar 

  • Xiao SH, Keiser J, Chollet J, Utzinger J, DongY EY, Vennerstrom JL, Tanner M (2007) In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob Agents Chemother 51:1440–1445

    Article  PubMed  CAS  Google Scholar 

  • Xiao SH, Zhang CW (2009) Histopathological alteration of juvenile Schistosoma japonicum in mice following treatment with single dose mefloquine. Parasitol Res 105:1733–1740

    Article  PubMed  Google Scholar 

  • Xiao SH, May JY, Jiao PY (2009a) Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum. Parasitol Res 106:131–138

    Article  PubMed  Google Scholar 

  • Xiao SH, May JY, Jiao PY (2009b) The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum. Parasitol Res 106:237–246

    Article  PubMed  Google Scholar 

  • Xiao SH, Chollet J, Utzinger J, Mei JY, Jiao P, Keiser J, Tanner M (2009c) Effect of single dose oral mefloquine on the morphology of adult Schistosoma japonicum in mice. Parasitol Res 105:853–861

    Article  PubMed  Google Scholar 

  • Xiao SH (2010) Progress in development of new antischistosomal drugs in recent years. Chin J Parasitol Parasitic Dis 28:218–225

    Google Scholar 

  • Xiao SH, Zhang CW (2010) Further observation on histopathological alterations of adult Schistosoma japonicum harbored in mice following treatment with mefloquine at a smaller single dose. Parasitol Res 107:773–781

    Article  PubMed  Google Scholar 

  • Xiao S, Keiser J, Chen MG, Tanner M, Utzinger J (2010a) Research and development of antischistosomal drugs in the People’s Republic of China: a 60-year review. Adv Parasitol 73:231–295

    Article  PubMed  Google Scholar 

  • Xiao SH, Xue J, Shen BG (2010b) Tegumental alterations of adult Schuistosoma japonicum harbored in mice treated with a single oral dose of mefloquine. Chin J Parasitol Parasitic Dis 28:1–7

    CAS  Google Scholar 

  • Xiao SH, Xue J, Shen BG (2010c) Transmission electron microscopic observation on ultrastructural alterations in Schistosoma japonicum caused by mefloquine. Parasitol Res 106:1179–1187

    Article  PubMed  Google Scholar 

  • Xiao SH, Xue J, Xu LL, Zhang YN, Qiang HQ (2010d) Effectiveness of mefloquine against Clonorchis sinensis in rats and Paragonimus westermani in dogs. Parasitol Res 107:1391–1397

    Article  PubMed  Google Scholar 

  • Xiao SH, Mei JY, Jiao PY (2011) Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum. Parasitol Res 108:399–406

    Article  PubMed  Google Scholar 

  • Xiao S, Sun J, Xue J (2012a) Confocal laser scanning microscopic observation on adult Schistosoma japonicum harbored in mice following treatment with single-dose mefloquine. Parasitol Res 110:2403–2411

    Article  PubMed  Google Scholar 

  • Xiao SH, Sun J, Xue J, Du XL, Zhang HB (2012b) Ultrastructural alterations of juvenile Schistosoma japonicum harbored in mice following mefloquine administration. Parasitol Res 110:637–644

    Article  PubMed  Google Scholar 

  • Xiao SH, Xue J, Zhang HB (2012c) Further studies on mefloquine and praziquantel alone or interaction of both drugs against Schistosoma japonicum in vitro. Parasitol Res 110:1239–1248

    Article  PubMed  Google Scholar 

  • Xiao SH, Zhang CW (2013) Preliminary observation on the effect of mefolquine against egg granuloma formation in the liver of mice infected with Schistosoma japonicum. Chin J Parasitol Parasitic Dis 31:81–86

    Google Scholar 

  • Yue WJ, You JQ, Mei JY (1985) Prophylactic activity of praziquantel in animals infected with Schistosoma japonicum. Acta Pharmacol Sin 6:186–188

    CAS  Google Scholar 

  • Yue WJ, Xiao SH, Mei JY (1989) Relationship between the effects of praziquantel on mice and rabbits with different intensities of Schistosoma japonicum infection and humoral immunity levels of the host. Acta Pharmacol Sin 10:476–479

    CAS  Google Scholar 

  • Zhang CW, Xiao SH, Utzinger J, Cholle J, Keiser J, Tanner M (2009) Histo- pathological changes in adult Schistosoma japonicum harbored in mice following treatment with mefloquine. Parasitol Res 104:1407–1416

    Article  PubMed  Google Scholar 

  • Zhang CW, Xiao SH (2012) Histopathological changes of juvenile Schistosoma japonicum harbored in mice treated orally with mefloquine at a smaller single dose. Parasitol Res 110:2281–2288

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, MOH, WHO Collaborating Centre for Malaria, Schistosomiasis, and Filariasis, Shanghai, 200025, People’s Republic of China

    Shu-hua Xiao

Authors
  1. Shu-hua Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shu-hua Xiao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiao, Sh. Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies. Parasitol Res 112, 3723–3740 (2013). https://doi.org/10.1007/s00436-013-3559-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-013-3559-0

Keywords

Search

Navigation